GLAXOSMITHKLINE AS
Score · fiscal year 2024
59of 100
How to read this: the company is ahead of 71 % of companies in the Morning class Large in the same sector in 2024. What does this mean?
Rank in the Morning class Large: 143 of 499 · What are Morning company classes?
Place in the whole sector: 7,267 of 22,333 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 57 and solidity 63 out of 100 among companies in the Morning class Large in the same sector in 2024. Methodology
Against the sector
GLAXOSMITHKLINE AS is 9 points above the median for companies in the Morning class Large in the same sector in 2024.
Median score 50 among 499 companies.
Against companies in the Morning class Large in the same sector in 2024: operating margin 3.2% (median 2.5%) and equity ratio 37.3% (median 28.8%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,039 MNOK | 1,161 MNOK |
| Operating margin | 3.2% | 2.5% |
| Profit margin | 3.4% | 2.6% |
| Return on assets | 11.6% | 10.1% |
| Equity ratio | 37.3% | 28.8% |
| Debt-to-equity | 1.68 | 2.43 |
| Current ratio | 1.17 | 1.26 |
| Revenue growth | 15.0% | 4.6% |
| Revenue per employee | 14.04 MNOK | 11.19 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 59, GLAXOSMITHKLINE AS does better than 71% of companies in the Morning class Large in the same sector (499 companies) in 2024.
Score 2023–2025
- GLAXOSMITHKLINE AS
- Median: companies in the Morning class Large in the same sector
What the numbers say
GLAXOSMITHKLINE AS had an operating margin of 3.2% and an equity ratio of 37.3% in 2024, and ranks 7,267 of 22,333 in Handel.
From 2023 to 2024: revenue grew by 15%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 118 MNOK and 277 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 262 MNOK |
| EV/EBIT | 8.0 | 277 MNOK |
| P/B | 1.0 | 118 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 1.0% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 57 | weight 30% |
|---|---|---|
| Solidity | 63 | weight 25% |
| Liquidity | 40 | weight 15% |
| Growth | 80 | weight 15% |
| Consistency | 57 | weight 15% |
Durability: 60 (average over 2 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is GLAXOSMITHKLINE AS?
The operating margin was 3.2% in 2024, against a median of 2.5% among companies in the Morning class Large in the same sector. Return on assets was 11.6%.
How solid is GLAXOSMITHKLINE AS?
The equity ratio was 37.3% in 2024 (median 28.8%). Debt-to-equity was 1.68 (median 2.43).
What is the liquidity of GLAXOSMITHKLINE AS like?
The current ratio was 1.17 in 2024 (median 1.26).
How does GLAXOSMITHKLINE AS compare in Handel?
GLAXOSMITHKLINE AS ranks 7,267 of 22,333 in Handel for 2024. Among companies in the Morning class Large it is number 143 of 499. Revenue changed by 15.0% from the year before.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
Public contracts
- Contracts awarded since 2024
- 0
- Total awarded value since 2024
- value not stated
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 17 October 2022 | Folkehelseinstituttet | Vaksine mot rotavirus | 0.0 MNOK |
| 10 November 2020 | Folkehelseinstituttet | HPV-vaksine i barnevaksinasjonsprogrammet | 0.0 MNOK (framework) |
| 28 July 2020 | Folkehelseinstituttet | Heksavalent vaksine - Kombinasjonsvaksine mot difteri, tetanus, kikhoste, polio, Hib og hepatitt B | value not stated |
| 8 August 2018 | Folkehelseinstituttet | Pandemisk influensavaksine | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 930606308
- Legal form
- AS · part of a group
- Sector
- Handel (46.460)
- Morning company class
- Large
- Employees
- 74 registered 10 October 2026
- Founded
- 25 August 1981 45 years in operation
- Share capital
- 0.95 MNOK
- Business address
- Drammensveien 288, 0283 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Omur Akalin Erin
- Chair of the board
- Omur Akalin Erin
- Auditor
- DELOITTE AS
- Accountant
- AMESTO ACCOUNTHOUSE AS
- Accountant
- KPMG ACCOUNTING AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 27 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 60 | 59 | 52 | |
| Rank | 7,228 | 7,267 | 10,706 | |
| Operating margin | 2.8% | 3.2% | 3.0% | |
| Return on assets | 9.8% | 11.6% | 9.7% | |
| Equity ratio | 39.8% | 37.3% | 28.0% | |
| Current ratio | 1.20 | 1.17 | 1.11 | |
| Revenue growth | – | 15.0% | 21.6% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 903.1 MNOK | 1,038.8 MNOK | 1,263.6 MNOK |
| Operating profit | 25.4 MNOK | 33.3 MNOK | 38.0 MNOK |
| Profit before tax | 27.8 MNOK | 34.9 MNOK | 38.9 MNOK |
| Net profit | 20.7 MNOK | 26.2 MNOK | 29.1 MNOK |
| Financial expenses | 0.9 MNOK | 1.9 MNOK | 2.2 MNOK |
| Total assets | 292.0 MNOK | 316.7 MNOK | 421.5 MNOK |
| Current assets | 210.3 MNOK | 232.2 MNOK | 335.3 MNOK |
| Equity | 116.3 MNOK | 118.1 MNOK | 118.1 MNOK |
| Retained earnings | 115.3 MNOK | 117.2 MNOK | 117.2 MNOK |
| Total liabilities | 175.7 MNOK | 198.6 MNOK | 303.4 MNOK |
| Current liabilities | 175.7 MNOK | 198.6 MNOK | 303.4 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 27 October 2026, accounts id 6015179.
Further
Similar companies
- MEGAFLIS AS index 60, rank 6,955 · compare
- ASKO MOLDE AS index 60, rank 6,961 · compare
- COAST SEAFOOD AS index 60, rank 7,146 · compare
- HELLY HANSEN AS index 59, rank 7,406 · compare
- VIANOR AS index 59, rank 7,430 · compare